Hester Biosciences indicates ED Priya Gandhi will address Q2 and H1 FY2025-26 earnings call on 12 Nov 2025, outlining strategic priorities to diversify revenue, expand geographic reach, and leverage H9N2 commercialization, with potential earnings uptick in H2 FY26.